Companies / EW vs ZBH
EW vs ZBH: Edwards Lifesciences and Zimmer Biomet Holdings
Edwards Lifesciences (EW) reported $6.1B in revenue against a 17.7% net margin, while Zimmer Biomet Holdings (ZBH) reported $8.2B at a 8.6% net margin, most recently.
| Metric | EW | ZBH |
|---|---|---|
| Revenue | $6.1B | $8.2B |
| Net Income | $1.1B | $0.7B |
| Gross Margin | 78.0% | 69.7% |
| Operating Margin | 20.8% | 13.3% |
| EPS (Diluted) | $1.83 | $3.55 |
| Free Cash Flow | $1.3B | $1.5B |
| Total Debt | $0.6B | $7.5B |
| P/E Ratio | 46.6× | 25.3× |
| P/B Ratio | 4.8× | n/m |
| Stock Price | $100.81 | $106.72 |
Free: last 5 years
| Fiscal year | FY2008 🔒 | FY2009 🔒 | FY2010 🔒 | FY2011 🔒 | FY2012 🔒 | FY2013 🔒 | FY2014 🔒 | FY2015 🔒 | FY2016 🔒 | FY2017 🔒 | FY2018 🔒 | FY2019 🔒 | FY2020 🔒 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EW Revenue | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $5.2B | $4.5B | $5.0B | $5.4B | $6.1B |
| ZBH Revenue | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $6.8B | $6.9B | $7.4B | $7.7B | $8.2B |